Clinical Trial Update: In Vivo Clinical Trial of Porous Starch - Hydroxyapatite Composite Biomaterials for Bone Regeneration

View source ↗

Summary

An in vivo clinical trial evaluating porous starch-hydroxyapatite composite biomaterials for bone regeneration has been completed. The trial targeted open fract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open Fracture of the Foot

Drugs mentioned

• Porous Starch - Hydroxyapatite Composite Biomaterial

Snippet

Sponsor: Chiang Mai University | Conditions: Open Fracture of Foot | Status: COMPLETED